# Efficacy and Safety of Oral DHEA Therapy for Postmenopausal Women on Sexual Function, Wellbeing and Vasomotor Symptoms

> **NCT00289926** · PHASE3 · COMPLETED · sponsor: **Monash University** · enrollment: 240 (actual)

## Conditions studied

- Quality of Life
- Menopausal Syndrome
- Libido Disorder

## Interventions

- **DRUG:** dehydroepiandrosterone
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00289926
- **Lead sponsor:** Monash University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2016-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00289926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00289926, "Efficacy and Safety of Oral DHEA Therapy for Postmenopausal Women on Sexual Function, Wellbeing and Vasomotor Symptoms". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00289926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*